approved EB-2 (NIW)

Researcher

Clinical Biochemistry · Iran · 2025-10-22

Processing Time
676 days
Decision Date
2025-10-22
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance mechanistic understanding and treatment strategies for diabetes, cardiovascular disease, and oral cancer. The work focuses on uncovering biochemical drivers of metabolic disorders and identifying biomarkers to support earlier diagnosis and improved patient outcomes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses chronic diseases with significant health and economic burdens in the U.S., supporting efforts to reduce healthcare costs.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., 16 publications, and 369 citations demonstrate an established record of scientific influence.

3 Waiver Benefit Met

On balance, the petitioner’s innovative work in clinical biochemistry fulfills national interest requirements, justifying the waiver of a job offer.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Chemical Pathology and a record of 16 peer-reviewed journal articles. The evidence included 369 citations from independent researchers and four expert recommendation letters. USCIS determined the work met all three Dhanasar prongs for a National Interest Waiver.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Tennessee 184 days 2022-10-04
The petitioner proposes to continue his research on the isolation and characterization of naturally sourced bioactive pharmacological compounds. This work focuses on developing new preventative and curative therapies for disorders such as diabetes mellitus, diabetic gastroparesis, and anxiety disorders.

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
New Jersey 6 days 2024-10-10
The petitioner proposes to develop advanced statistical models using real-world evidence and omics data to identify novel biomarkers for diseases. This work aims to facilitate the development of precision drug therapies and enhance the understanding of cancer, metabolic disorders, and cardiovascular diseases.

Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) rfe approved
Illinois 367 days 2025-11-28
The petitioner proposes to use in-depth analysis of biological and chemical samples to advance the understanding of cellular reactions and mechanisms. Her work aims to devise biochemical and biomedical strategies to combat diseases and resolve urgent biomedical challenges, directly improving therapeutic development and public health outcomes.

Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
88 days 2022-04-01
The petitioner proposes to develop disease transmission models and identify disease-related gene loci to perform in-depth studies on widespread diseases such as heart disease and cancer. Her work aims to provide frameworks for more effective disease control policies and clinical strategies to improve patient outcomes.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-10-22.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 676 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist